(Q45734539)

English

Cross-clade neutralizing antibody production against human immunodeficiency virus type 1 clade E and B' strains by recombinant Mycobacterium bovis BCG-based candidate vaccine

scientific article published in December 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Cross-clade neutralizing antibody production against human immunodeficiency virus type 1 clade E and B' strains by recombinant Mycobacterium bovis BCG-based candidate vaccine (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Mycobacterium bovis

1 reference

based on heuristic

inferred from title

author name string

Chujoh Y

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Matsuo K

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Yoshizaki H

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Nakasatomi T

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Someya K

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Okamoto Y

6

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Naganawa S

7

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Haga S

8

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Yoshikura H

9

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Yamazaki A

10

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Yamazaki S

11

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Honda M

12

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

language of work or name

0 references

publication date

1 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

5-6

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

797-804

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A characteristic change of consensus core motif in the V3 region of HIV type 1 clade B, but not in clade E, in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Failure of a human immunodeficiency virus type 1 (HIV-1) subtype B-derived vaccine to prevent infection of chimpanzees by an HIV-1 subtype E strain

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of bivalent (B/E) vaccines able to neutralize CCR5-dependent viruses from the United States and Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

AIDSVAX (MN) in Bangkok injecting drug users: a report on safety and immunogenicity, including macrophage-tropic virus neutralization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytotoxic T lymphocyte response in mice induced by a recombinant BCG vaccination which produces an extracellular alpha antigen that fused with the human immunodeficiency virus type 1 envelope immunodominant domain in the V3 loop

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

New use of BCG for recombinant vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium bovis bacillus Calmette-Guérin vector candidate vaccine for human immunodeficiency virus type 1 in small animals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Antigenic variation and serotyping of HIV type 1 from four World Health Organization-sponsored HIV vaccine sites. WHO Network for HIV Isolation and Characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A highly pathogenic simian/human immunodeficiency virus with genetic changes in cynomolgus monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunoglobulin G (IgG) and IgA, but also nonantibody factors, account for in vitro neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by serum and plasma of HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved Humoral and Cellular Immune Responses Against the gp120 V3 Loop of HIV-1 Following Genetic Immunization with a Chimeric DNA Vaccine Encoding the V3 Inserted into the Hepatitis B Surface Antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of V3 loop-Pseudomonas exotoxin chimeras. Candidate vaccines for human immunodeficiency virus-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccine-elicited V3 loop-specific antibodies in rhesus monkeys and control of a simian-human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate envelope

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunotyping of human immunodeficiency virus type 1 (HIV): an approach to immunologic classification of HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody binding and neutralization of primary and T-cell line-adapted isolates of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of antibodies in guinea pigs and rhesus monkeys against the human immunodeficiency virus type 1 envelope: neutralization of nonpathogenic and pathogenic primary isolate simian/human immunodeficiency virus strains

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Elicitation of protective immunity against simian immunodeficiency virus infection by a recombinant Sendai virus expressing the Gag protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Quintuple deglycosylation mutant of simian immunodeficiency virus SIVmac239 in rhesus macaques: robust primary replication, tightly contained chronic infection, and elicitation of potent immunity against the parental wild-type strain

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(01)00398-X

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

release_h7fcramnbvdljjkijlecjbx2i4

1 reference

https://api.fatcat.wiki/v0/release/h7fcramnbvdljjkijlecjbx2i4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45734539&oldid=2154121721"